These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23239832)

  • 21. Role of NADPH oxidase in retinal vascular inflammation.
    Al-Shabrawey M; Rojas M; Sanders T; Behzadian A; El-Remessy A; Bartoli M; Parpia AK; Liou G; Caldwell RB
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3239-44. PubMed ID: 18378574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring inflammation injuries in the progression of atherosclerosis with contrast enhanced ultrasound molecular imaging.
    Sun R; Tian J; Zhang J; Wang L; Guo J; Liu Y
    PLoS One; 2017; 12(10):e0186155. PubMed ID: 28982198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1.
    Kaufmann BA; Sanders JM; Davis C; Xie A; Aldred P; Sarembock IJ; Lindner JR
    Circulation; 2007 Jul; 116(3):276-84. PubMed ID: 17592078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization.
    Monaghan-Benson E; Hartmann J; Vendrov AE; Budd S; Byfield G; Parker A; Ahmad F; Huang W; Runge M; Burridge K; Madamanchi N; Hartnett ME
    Am J Pathol; 2010 Oct; 177(4):2091-102. PubMed ID: 20802176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
    Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
    J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence against the involvement of multiple radical generating sites in the expression of the vascular cell adhesion molecule-1.
    Pietersma A; de Jong N; de Wit LE; Kraak-Slee RG; Koster JF; Sluiter W
    Free Radic Res; 1998 Feb; 28(2):137-50. PubMed ID: 9645391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.
    Manea SA; Vlad ML; Fenyo IM; Lazar AG; Raicu M; Muresian H; Simionescu M; Manea A
    Redox Biol; 2020 Jan; 28():101338. PubMed ID: 31634818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases.
    Yu J; Weïwer M; Linhardt RJ; Dordick JS
    Curr Vasc Pharmacol; 2008 Jul; 6(3):204-17. PubMed ID: 18673160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice.
    Choi BY; Kim JH; Kho AR; Kim IY; Lee SH; Lee BE; Choi E; Sohn M; Stevenson M; Chung TN; Kauppinen TM; Suh SW
    J Neuroinflammation; 2015 May; 12():104. PubMed ID: 26017142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of NADPH oxidase inhibition on cardiopulmonary bypass-induced lung injury.
    Dodd-o JM; Welsh LE; Salazar JD; Walinsky PL; Peck EA; Shake JG; Caparrelli DJ; Ziegelstein RC; Zweier JL; Baumgartner WA; Pearse DB
    Am J Physiol Heart Circ Physiol; 2004 Aug; 287(2):H927-36. PubMed ID: 15277207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrasound Molecular Imaging of Atherosclerosis Using Small-Peptide Targeting Ligands Against Endothelial Markers of Inflammation and Oxidative Stress.
    Moccetti F; Weinkauf CC; Davidson BP; Belcik JT; Marinelli ER; Unger E; Lindner JR
    Ultrasound Med Biol; 2018 Jun; 44(6):1155-1163. PubMed ID: 29548756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain.
    Kapoor M; Sharma N; Sandhir R; Nehru B
    Biomed Pharmacother; 2018 Jan; 97():458-472. PubMed ID: 29091896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect of reinioside C on monocyte-endothelial cell adhesion induced by oxidized low-density lipoprotein via inhibiting NADPH oxidase/ROS/NF-kappaB pathway.
    Bai YP; Hu CP; Chen MF; Xu KP; Tan GS; Shi RZ; Li YJ; Zhang GG
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):399-406. PubMed ID: 19730822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase.
    Matheny HE; Deem TL; Cook-Mills JM
    J Immunol; 2000 Jun; 164(12):6550-9. PubMed ID: 10843714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
    Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension.
    Tian N; Moore RS; Phillips WE; Lin L; Braddy S; Pryor JS; Stockstill RL; Hughson MD; Manning RD
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1858-65. PubMed ID: 18922960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation inhibition and gut microbiota regulation by TSG to combat atherosclerosis in ApoE
    Li F; Zhang T; He Y; Gu W; Yang X; Zhao R; Yu J
    J Ethnopharmacol; 2020 Jan; 247():112232. PubMed ID: 31606534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.
    Hood ED; Greineder CF; Dodia C; Han J; Mesaros C; Shuvaev VV; Blair IA; Fisher AB; Muzykantov VR
    J Control Release; 2012 Oct; 163(2):161-9. PubMed ID: 22974832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.